banner
Relative Quantification of Glycoprotein

Relative Quantification of Glycoprotein

Overview

Protein glycosylation, the most common post-translational modification process in eukaryotic cells, plays a crucial role in the correct biological function of proteins. Studies have shown that many diseases are accompanied by abnormal changes in the structure and expression of glycan chains on the intracellular glycoprotein. The detection of abnormal expression of glycoprotein chains can be used as a signal of cellular pathology. Therefore, glycans can be used as biomarkers for the diagnosis of certain diseases.

To understand the roles of glycoproteins in numerous disease mechanisms that depend on glycan-protein binding, it is critical to quantify glycoproteins at the site-specific glycosylation level, protein level, and glycosylation occupancy level. At present, the relative quantitative and qualitative analysis of glycan samples from different sources can be carried out by the combination of isotope labeling and modern biological mass spectrometry techniques, to investigate whether and how differently glycan chains are expressed in different samples. In addition, several effective strategies have been described for glycoprotein quantification, such as lectin microarrays, liquid chromatography-mass spectrometry (LC-MS), normal-phase high-performance liquid chromatography (HPLC), and multiple reaction monitoring (MRM).

Quantitative measurements of N-linked glycoproteins by SRM or SWATH-MS.Fig.1 Quantitative measurements of N-linked glycoproteins by SRM or SWATH-MS. (Liu, 2013)

Your Best Partner in Glycoprotein Relative Quantification Services

Our company provides relative quantification of glycoproteins, which is designed to provide insight into how complex glycosylation modifications affect protein function, disease states, and the properties of biopharmaceuticals. We utilize advanced MS to enable precise comparisons of glycoproteins in different samples, providing clients with multi-dimensional information on glycosylation.

  • Relative Quantitative Analysis
    • Our lab analyzes the relative quantification of glycoproteins in different samples using an internal standard method or standard curve method to provide the most accurate test for our clients.
    • Our researchers calculate the relative amount of glycoproteins in each sample and compare the differences between different samples.

Relative quantification of Glycoprotein at the Site Specific Glycosylation Level

This service focuses on comparing the relative abundance of the same glycoprotein with a specific glycan structure in different samples. Our service can be used to analyze whether the level of a specific type of N-glycan or O-glycan (e.g., hypersalivation, fucosylation, altered branching, etc.) modification is increasing or decreasing on a key glycoprotein.

Relative quantification of Glycoprotein at the Protein Level

Research teams of CD BioGlyco have applied advanced techniques in proteomics to the study of glycoproteins, successfully achieving relative quantification of glycoproteins at the protein level. We provide relative quantitative analysis of glycosylation modifications as well as glycoprotein core protein abundance.

Relative quantification of Glycoprotein at the Glycosylation Occupancy Level

CD BioGlyco has established multiple methods for rapid and accurate relative quantification of glycoproteins at the glycosylation occupancy level, providing customers with technical support in studying glycoproteins' functions. This service is designed to quantify the presence or absence of glycosylation at a particular glycosylation site and the relative change in the extent or frequency with which the site is modified by glycosylation.

Workflow

Schematic diagram of glycoprotein relative quantification service.

Applications

  • Disease Marker Screening: By comparing the expression levels of glycoproteins in different disease states, our relative quantification service can be used to screen potential disease markers.
  • Glycosylation Modification Research: Our services can be used to study the function of glycosylated modified proteins in life activities, revealing their regulatory roles in cell signaling, biological processes.
  • Glycosylation modifications have important effects on the pharmacokinetics and immunogenicity of drugs. Our quantitative services can be used to monitor and control them.

Advantages of Us

  • Our company provides standardized procedures for sample handling, on-board analysis, data analysis, and project reporting to ensure reproducible and reliable results.
  • We use advanced LC and specific enrichment methods to detect low-abundance glycoproteins and ensure analytical specificity.
  • We provide non-labeled MS quantitative analysis services without isotope labeling, shortening project cycle time and increasing detection sensitivity.

Frequently Asked Questions

Relative quantification of glycoprotein has been recognized as an important method for analyzing the physiological state or pathological status of cells. CD BioGlyco has completed many glycoprotein quantification cases. As a biotechnology company in the field of glycobiology, we expect to revolutionize your project and contribute to your success. If you have special requirements, please contact us for further information. We will do our best to provide you with the optimal service.

Associated Services

Reference

  1. Xu, S.; et al. Deciphering the properties and functions of glycoproteins using quantitative proteomics. Journal of Proteome Research. 2023, 22(6): 1571-1588. (Open Access)
This service is for Research Use Only, not intended for any clinical use.
Quick Links
Resources

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0